aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.98 USD 1.79% Market Closed
Market Cap: 334.1m USD
Have any thoughts about
aTyr Pharma Inc?
Write Note

Relative Value

The Relative Value of one ATYR stock under the Base Case scenario is 4.75 USD. Compared to the current market price of 3.98 USD, aTyr Pharma Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATYR Relative Value
Base Case
4.75 USD
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
Median 3Y
17
Median 5Y
38.2
Industry
7.5
Forward
1 326.7
vs History
vs Industry
Median 3Y
-4
Median 5Y
-6.8
Industry
21.3
Forward
-4.3
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-7.2
Industry
21.6
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-7.1
Industry
23.3
vs History
0
vs Industry
Median 3Y
2.4
Median 5Y
3.9
Industry
2.5
vs History
0
vs Industry
Median 3Y
7.2
Median 5Y
33.3
Industry
7.4
Forward
1 068.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-4.6
Industry
4.2
Forward
-4
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-4.6
Industry
4
Forward
-3.7
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-4.9
Industry
6.1
vs History
vs Industry
Median 3Y
-2.5
Median 5Y
-4.9
Industry
3.9
vs History
0
vs Industry
Median 3Y
4.2
Median 5Y
32.8
Industry
4.6

Multiples Across Competitors

ATYR Competitors Multiples
aTyr Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
aTyr Pharma Inc
NASDAQ:ATYR
334.1m USD 1 421.6 -5.2 -4 -4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 535 597.3 -183 154 -222 407.2 -219 869.3
US
Abbvie Inc
NYSE:ABBV
320.2B USD 5.8 63 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
140.4B USD 4.3 33.2 15.9 30.2
US
Gilead Sciences Inc
NASDAQ:GILD
113.9B USD 4 903.9 10 10
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.9B USD 9.9 -218.7 21.6 22.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 828.2 -466.5 -508 -494.5
AU
CSL Ltd
ASX:CSL
137.2B AUD 5.8 32.3 20 24.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD 5.7 17 15.4 17.2
US
Seagen Inc
F:SGT
39.3B EUR 17.6 -54 -58 -52.3
NL
argenx SE
XBRU:ARGX
36.6B EUR 17.2 -334 -158.3 -103.1
P/S Multiple
Revenue Growth P/S to Growth
US
aTyr Pharma Inc
NASDAQ:ATYR
Average P/S: 3 503 537.9
1 421.6
377%
3.8
FR
Pharnext SCA
OTC:PNEXF
38 535 597.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
6%
1
US
Amgen Inc
NASDAQ:AMGN
4.3
8%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
4
3%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
1 828.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5.8
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
7%
0.8
US
S
Seagen Inc
F:SGT
17.6
30%
0.6
NL
argenx SE
XBRU:ARGX
17.2
47%
0.4
P/E Multiple
Earnings Growth PEG
US
aTyr Pharma Inc
NASDAQ:ATYR
Average P/E: 209.9
Negative Multiple: -5.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -183 154 N/A N/A
US
Abbvie Inc
NYSE:ABBV
63
72%
0.9
US
Amgen Inc
NASDAQ:AMGN
33.2
20%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
903.9
21%
43
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -218.7
14%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -466.5 N/A N/A
AU
CSL Ltd
ASX:CSL
32.3
18%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
13%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -334 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
aTyr Pharma Inc
NASDAQ:ATYR
Average EV/EBITDA: 16.4
Negative Multiple: -4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -222 407.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.6
9%
1.7
US
Amgen Inc
NASDAQ:AMGN
15.9
18%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10
5%
2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.6
13%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -508 N/A N/A
AU
CSL Ltd
ASX:CSL
20
12%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
11%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -158.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
aTyr Pharma Inc
NASDAQ:ATYR
Average EV/EBIT: 21.5
Negative Multiple: -4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 869.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.1
24%
1
US
Amgen Inc
NASDAQ:AMGN
30.2
24%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
10
10%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.7
13%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -494.5 N/A N/A
AU
CSL Ltd
ASX:CSL
24.9
16%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
12%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -52.3 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.1 N/A N/A